| Bioactivity | Pegylated synthetic human c-peptide retains bioactivity comparable to that of natural (i.e. non-polyethylene glycolated) C-peptides and has a prolonged circulating residence time in plasma for use in diabetic peripheral neuropathy studies[1]. |
| Name | Pegylated synthetic human c-peptide |
| CAS | 1350661-05-0 |
| Sequence | Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln |
| Shortening | EAEDLQVGQVELGGGPGAGSLQPLALEGSLQ |
| Formula | C129H211N35O48 |
| Molar Mass | 3018.52 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Pegylated synthetic human c-peptide
CAS: 1350661-05-0 F: C129H211N35O48 W: 3018.52
Pegylated synthetic human c-peptide retains bioactivity comparable to that of natural (i.e. non-polyethylene glycolated)
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.